Dürdane Aksoy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dürdane Aksoy has a total of 153 co-authors. Here are the top co-authors by number of shared publications:
- Volkan Solmaz
Memorial hizmet hospital, neurology clinic, Istanbul, Turkey
7 shared publications - Semiha Kurt
Department of Neurology, Gaziosmanpasa University Faculty of Medicine, Tokat, Turkey
5 shared publications - Betul Cevik
Tokat Gaziosmanpasa University Medical Faculty, Department of Neurology, Tokat, Turkey
4 shared publications Semiha Kurt
Faculty of Medicine, Department of Neurology, Tokat Gaziosmanpasa University, Kaleardi mah. Muhittin Fusunoglu cad, 60100, Tokat, Turkey
4 shared publicationsBetul Cevik
Gaziosmanpasa University, Faculty of Medicine, Department of Neurology, Muhittin Fusunoglu cd., 60100 Tokat, Turkey
3 shared publicationsBetül Çevik
Tokat Gaziosmanpaşa University, Faculty of Medicine, Department of Neurology, Tokat, Turkey
3 shared publications
Latest Publications
- 9 September 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (10) , 766
Exploring the Type 4 Cerebrospinal Fluid Oligoclonal Band Pattern: Clinical and Paraclinical Features with Diagnostic Implications
- 9 September 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (10) , 766
Exploring the Type 4 Cerebrospinal Fluid Oligoclonal Band Pattern: Clinical and Paraclinical Features with Diagnostic Implications
- 26 February 2026
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 109, 107098
Effect of laughter yoga on fatigue, sleep quality and psychological well-being in people with multiple sclerosis: A randomized controlled trial
- 26 February 2026
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 109, 107098
Effect of laughter yoga on fatigue, sleep quality and psychological well-being in people with multiple sclerosis: A randomized controlled trial
- 4 April 2025
- Published by Nobel Tip Kitabevleri
Aile Hekimliğinde Kronik Hastalıkların Yönetimi
Aile Hekimliğinde Kronik Hastalıkların Yönetimi kitabı, birinci basamak sağlık hizmetlerinde kronik hastalıkların etkin yönetimi için kapsamlı ve kanıta dayalı bir rehber sunmaktadır. Aile hekimliği uzmanları, birinci basamak hekimleri, aile sağlığı çalışanları, ebeler, hemşireler ve sağlık yöneticileri için hazırlanmış bu kaynak, kronik hastalıkların tanı, tedavi ve takip süreçlerine dair güncel bilgiler içermektedir.rnrn● Aile Hekimliği İlkeleri ile Birinci Basamakta Kronik Hastalık Yönetimi: Bu kitap, Aile Hekimliği İlkeleri kapsamında aile hekimlerinin kronik hastalıkları etkin bir şekilde yönetebilmesi için bilimsel temellere dayalı rehberlik sunmaktadır.rnrn● Hasta Merkezli Bütüncül, Sürekli, Kapsamlı ve Multidisipliner Yaklaşım: Kardiyovasküler Hastalıklar, Diyabet, KOAH, Geriatrik ve Mental Sağlık gibi yaygın kronik hastalıkların yönetiminde ekip çalışmasının ve bireyselleştirilmiş bakımın önemini vurgulamaktadır. Kronik hastalıklarla yaşayan bireylerin yönetiminde aile hekimliğinin temel prensipleri içinde bütüncül, sürekli, kapsamlı ve multidisipliner bakım stratejilerinin uygulamalarına odaklanmaktadır.rnrn● Güncel Bilgiler, Klinik Rehberler ve Uygulamalar: Kanıta dayalı güncel tıbbi bilgileri, tedavi yaklaşımlarını ve birinci basamakta uygulanabilir pratik önerileri içermektedir.rnrn● Aile Hekimleri İçin Kapsamlı Bir Kaynak: Aile Hekimliği Uzmanları, Birinci Basamak Hekimleri, aile sağlığı çalışanları, ebeler, hemşireler ve sağlık yöneticileri için rehber niteliğinde hazırlanmış olup, kronik hastalıklarla mücadelede etkili stratejiler sunmaktadır.rnrn● Sağlık Hizmetlerinin Geleceğine Katkı: Birinci basamak sağlık hizmetlerinde kronik hastalık yönetiminin kalitesini artırmayı amaçlayan bu eser, hasta bakım süreçlerinde sürdürülebilir iyileşmeler sağlamak için önemli bir başvuru kaynağı olacaktır.rnrn● Eleştirel Düşünme Soruları: Bu kitap, kronik hastalıkların yönetimi ile ilgili temel kavramları daha iyi anlamanızı sağlayacak tartışma soruları ile düşünce ufkunuzu genişletecek önerileri içermektedirrnrn● Öğrenme Hedefleri ve Anahtar Kavramlar: Kitap boyunca odaklanmanız gereken temel noktaları belirleyerek, klinik pratiğinize yön verecek güncel bilgilere erişiminizi sağlayacaktır.rnrn rnrn“Birinci basamak sağlık hizmetlerinde kronik hastalıkların yönetimi, bütüncül bir yaklaşımı zorunlu kılar. Kronik hastalıkların yönetimi, sadece tedavi süreçlerini değil, hastaların yaşam kalitesini artırmayı da gerektirir. Bu kitap, aile hekimleri için pratik ve güncel bilgilerle donatılmış kapsamlı bir rehber niteliği içererek, aile hekimlerinin karşılaştıkları zorluklara kanıta dayalı çözümler sunarak önemli bir boşluğu dolduracaktır.”rn— Prof. Dr. Yeltekin Demirelrnrn“Günümüzde kronik hastalıklar, sağlık sisteminin en büyük yüklerinden biri haline gelmiştir. Bu kitap, aile hekimleri için yalnızca bir kaynak değil, aynı zamanda hastalarıyla etkili iletişim kurmalarına yardımcı olacak bir yol haritası oluşturarak daha kaliteli sağlık hizmet sunumunu sağlayacaktır.”rn— Prof. Dr. Süleyman Görpelioğlurnrn“Kronik hastalıkların yönetimi, hekim-hasta iş birliğini ve bireyselleştirilmiş bakım yaklaşımlarını gerektirir. Bu kitap, aile hekimlerinin hastalarına daha etkin bir rehberlik yapabilmesi için güçlü bir içerik sunuyor. Birinci Basamak Sağlık Hizmetlerinde çalışan tüm sağlık profesyonellerinin önemli başvuru kitabı niteliğinde...”rn— Prof. Dr. Serpil Demirağ
- 4 April 2025
- Published by Nobel Tip Kitabevleri
Aile Hekimliğinde Kronik Hastalıkların Yönetimi
Aile Hekimliğinde Kronik Hastalıkların Yönetimi kitabı, birinci basamak sağlık hizmetlerinde kronik hastalıkların etkin yönetimi için kapsamlı ve kanıta dayalı bir rehber sunmaktadır. Aile hekimliği uzmanları, birinci basamak hekimleri, aile sağlığı çalışanları, ebeler, hemşireler ve sağlık yöneticileri için hazırlanmış bu kaynak, kronik hastalıkların tanı, tedavi ve takip süreçlerine dair güncel bilgiler içermektedir.rnrn● Aile Hekimliği İlkeleri ile Birinci Basamakta Kronik Hastalık Yönetimi: Bu kitap, Aile Hekimliği İlkeleri kapsamında aile hekimlerinin kronik hastalıkları etkin bir şekilde yönetebilmesi için bilimsel temellere dayalı rehberlik sunmaktadır.rnrn● Hasta Merkezli Bütüncül, Sürekli, Kapsamlı ve Multidisipliner Yaklaşım: Kardiyovasküler Hastalıklar, Diyabet, KOAH, Geriatrik ve Mental Sağlık gibi yaygın kronik hastalıkların yönetiminde ekip çalışmasının ve bireyselleştirilmiş bakımın önemini vurgulamaktadır. Kronik hastalıklarla yaşayan bireylerin yönetiminde aile hekimliğinin temel prensipleri içinde bütüncül, sürekli, kapsamlı ve multidisipliner bakım stratejilerinin uygulamalarına odaklanmaktadır.rnrn● Güncel Bilgiler, Klinik Rehberler ve Uygulamalar: Kanıta dayalı güncel tıbbi bilgileri, tedavi yaklaşımlarını ve birinci basamakta uygulanabilir pratik önerileri içermektedir.rnrn● Aile Hekimleri İçin Kapsamlı Bir Kaynak: Aile Hekimliği Uzmanları, Birinci Basamak Hekimleri, aile sağlığı çalışanları, ebeler, hemşireler ve sağlık yöneticileri için rehber niteliğinde hazırlanmış olup, kronik hastalıklarla mücadelede etkili stratejiler sunmaktadır.rnrn● Sağlık Hizmetlerinin Geleceğine Katkı: Birinci basamak sağlık hizmetlerinde kronik hastalık yönetiminin kalitesini artırmayı amaçlayan bu eser, hasta bakım süreçlerinde sürdürülebilir iyileşmeler sağlamak için önemli bir başvuru kaynağı olacaktır.rnrn● Eleştirel Düşünme Soruları: Bu kitap, kronik hastalıkların yönetimi ile ilgili temel kavramları daha iyi anlamanızı sağlayacak tartışma soruları ile düşünce ufkunuzu genişletecek önerileri içermektedirrnrn● Öğrenme Hedefleri ve Anahtar Kavramlar: Kitap boyunca odaklanmanız gereken temel noktaları belirleyerek, klinik pratiğinize yön verecek güncel bilgilere erişiminizi sağlayacaktır.rnrn rnrn“Birinci basamak sağlık hizmetlerinde kronik hastalıkların yönetimi, bütüncül bir yaklaşımı zorunlu kılar. Kronik hastalıkların yönetimi, sadece tedavi süreçlerini değil, hastaların yaşam kalitesini artırmayı da gerektirir. Bu kitap, aile hekimleri için pratik ve güncel bilgilerle donatılmış kapsamlı bir rehber niteliği içererek, aile hekimlerinin karşılaştıkları zorluklara kanıta dayalı çözümler sunarak önemli bir boşluğu dolduracaktır.”rn— Prof. Dr. Yeltekin Demirelrnrn“Günümüzde kronik hastalıklar, sağlık sisteminin en büyük yüklerinden biri haline gelmiştir. Bu kitap, aile hekimleri için yalnızca bir kaynak değil, aynı zamanda hastalarıyla etkili iletişim kurmalarına yardımcı olacak bir yol haritası oluşturarak daha kaliteli sağlık hizmet sunumunu sağlayacaktır.”rn— Prof. Dr. Süleyman Görpelioğlurnrn“Kronik hastalıkların yönetimi, hekim-hasta iş birliğini ve bireyselleştirilmiş bakım yaklaşımlarını gerektirir. Bu kitap, aile hekimlerinin hastalarına daha etkin bir rehberlik yapabilmesi için güçlü bir içerik sunuyor. Birinci Basamak Sağlık Hizmetlerinde çalışan tüm sağlık profesyonellerinin önemli başvuru kitabı niteliğinde...”rn— Prof. Dr. Serpil Demirağ
- 26 November 2024
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 248, 108665
Restless legs syndrome associated with teriflunomide use in two patients with multiple sclerosis
- 26 November 2024
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 248, 108665
Restless legs syndrome associated with teriflunomide use in two patients with multiple sclerosis
- Open Access
- 3 June 2024
- Published by Galenos Yayinevi in Balkan Medical Journal
- Vol. 41 (4) , 272-279
Clinical, Demographic, and Radiological Characteristics of Patients Demonstrating Antibodies Against Myelin Oligodendrocyte Glycoprotein
Optic neuritis, myelitis, and neuromyelitis optica spectrum disorder (NMOSD) have been associated with antibodies against myelin oligodendrocyte glycoprotein-immunoglobulin G (anti-MOG-IgG). Furthermore, patients with radiological and demographic features atypical for multiple sclerosis (MS) with optic neuritis and myelitis also demonstrate antibodies against aquaporin-4 and anti-MOG-IgG. However, data on the diagnosis, treatment, follow-up, and prognosis in patients with anti-MOG-IgG are limited. To evaluate the clinical, radiological, and demographic characteristics of patients with anti-MOG-IgG. Multicenter, retrospective, observational study. Patients with blood samples demonstrating anti-MOG-IgG that had been evaluated at the Neuroimmunology laboratory at Ondokuz Mayıs University's Faculty of Medicine were included in the study. Of the 104 patients with anti-MOG-IgG, 56.7% were women and 43.3% were men. Approximately 2.4% of the patients were diagnosed with MS, 15.8% with acute disseminated encephalomyelitis (ADEM), 39.4% with NMOSD, 31.3% with isolated optic neuritis, and 11.1% with isolated myelitis. Approximately 53.1% of patients with spinal involvement at clinical onset demonstrated a clinical course of NMOSD. Thereafter, 8.8% of these patients demonstrated a clinical course similar to MS and ADEM, and 28.1% demonstrated a clinical course of isolated myelitis. The response to acute attack treatment was lower and the disability was higher in patients aged > 40 years than patients aged < 40 years at clinical onset. Oligoclonal band was detected in 15.5% of the patients. For patients with NMOSD and without anti-NMO antibodies, the diagnosis is supported by the presence of anti-MOG-IgG. Furthermore, advanced age at clinical onset, Expanded Disability Status Scale (EDSS) score at clinical onset, spinal cord involvement, and number of attacks may be negative prognostic factors in patients with anti-MOG-IgG.
- 3 June 2024
- Published by Galenos Yayinevi in Balkan Medical Journal
- Vol. 41 (4) , 272-279
Open AccessClinical, Demographic, and Radiological Characteristics of Patients Demonstrating Antibodies Against Myelin Oligodendrocyte Glycoprotein
Optic neuritis, myelitis, and neuromyelitis optica spectrum disorder (NMOSD) have been associated with antibodies against myelin oligodendrocyte glycoprotein-immunoglobulin G (anti-MOG-IgG). Furthermore, patients with radiological and demographic features atypical for multiple sclerosis (MS) with optic neuritis and myelitis also demonstrate antibodies against aquaporin-4 and anti-MOG-IgG. However, data on the diagnosis, treatment, follow-up, and prognosis in patients with anti-MOG-IgG are limited. To evaluate the clinical, radiological, and demographic characteristics of patients with anti-MOG-IgG. Multicenter, retrospective, observational study. Patients with blood samples demonstrating anti-MOG-IgG that had been evaluated at the Neuroimmunology laboratory at Ondokuz Mayıs University's Faculty of Medicine were included in the study. Of the 104 patients with anti-MOG-IgG, 56.7% were women and 43.3% were men. Approximately 2.4% of the patients were diagnosed with MS, 15.8% with acute disseminated encephalomyelitis (ADEM), 39.4% with NMOSD, 31.3% with isolated optic neuritis, and 11.1% with isolated myelitis. Approximately 53.1% of patients with spinal involvement at clinical onset demonstrated a clinical course of NMOSD. Thereafter, 8.8% of these patients demonstrated a clinical course similar to MS and ADEM, and 28.1% demonstrated a clinical course of isolated myelitis. The response to acute attack treatment was lower and the disability was higher in patients aged > 40 years than patients aged < 40 years at clinical onset. Oligoclonal band was detected in 15.5% of the patients. For patients with NMOSD and without anti-NMO antibodies, the diagnosis is supported by the presence of anti-MOG-IgG. Furthermore, advanced age at clinical onset, Expanded Disability Status Scale (EDSS) score at clinical onset, spinal cord involvement, and number of attacks may be negative prognostic factors in patients with anti-MOG-IgG.
- 31 August 2022
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 32 (4) , 451-454
Nerve conduction studies in the early diagnosis of amyotrophic lateral sclerosis and the importance of split-hand phenomenon
Aim: The heterogeneity of the Amyotrophic Lateral Sclerosis (ALS) clinical phenotypes leads to difficulties in early diagnosis. The ‘split hand’ sign is defined as the thenar muscles that are more prominently affected by hypothenar. In this study, the results of the initial nerve conduction study of the patients were compared with those of the controls in order to increase the findings supporting early diagnosis. Material and Method: Seventy-five patients who were diagnosed with ALS in our clinic were included in the study. The initial ENMG findings of the patients were compared with those of 70 healthy controls: Distal motor latency (DML), the compound muscle action potential (CMAP) amplitude, velocity in the motor conduction of median, ulnar, peroneal and tibial nerves; distal latency, amplitude, velocity in sensorial conduction were evaluated. Ulnar/median DML and ulnar/median CMAP amplitude ratios were examined. Results: In ALS group, DMLs of the median, ulnar, peroneal, and tibial nerves were significantly longer, and CMAP amplitudes were significantly smaller than those of the controls. The sensory conductions of the median, ulnar, and sural nerves were not statistically different between the groups. The ulnar/median DML ratio of the patients was lower than the ratio of controls (0.73/0.80;p=0.003); while the ulnar/median CMAP amplitude ratio was greater (1.40/1.11; p=0.002). Conclusion: Prolonged DML and reduced amplitudes were observed in the motor nerve conduction of ALS patients in the early period. The results of the present study also support the presence of split-hand phenomenon even in early period of limb-onset ALS (both upper and lower). These findings suggest that nerve conduction studies and electrophysiologically detected split-hand sign are important clues for the early diagnosis of ALS in case of heterogeneous clinical phenotype.
- 31 August 2022
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 32 (4) , 451-454
Nerve conduction studies in the early diagnosis of amyotrophic lateral sclerosis and the importance of split-hand phenomenon
Aim: The heterogeneity of the Amyotrophic Lateral Sclerosis (ALS) clinical phenotypes leads to difficulties in early diagnosis. The ‘split hand’ sign is defined as the thenar muscles that are more prominently affected by hypothenar. In this study, the results of the initial nerve conduction study of the patients were compared with those of the controls in order to increase the findings supporting early diagnosis. Material and Method: Seventy-five patients who were diagnosed with ALS in our clinic were included in the study. The initial ENMG findings of the patients were compared with those of 70 healthy controls: Distal motor latency (DML), the compound muscle action potential (CMAP) amplitude, velocity in the motor conduction of median, ulnar, peroneal and tibial nerves; distal latency, amplitude, velocity in sensorial conduction were evaluated. Ulnar/median DML and ulnar/median CMAP amplitude ratios were examined. Results: In ALS group, DMLs of the median, ulnar, peroneal, and tibial nerves were significantly longer, and CMAP amplitudes were significantly smaller than those of the controls. The sensory conductions of the median, ulnar, and sural nerves were not statistically different between the groups. The ulnar/median DML ratio of the patients was lower than the ratio of controls (0.73/0.80;p=0.003); while the ulnar/median CMAP amplitude ratio was greater (1.40/1.11; p=0.002). Conclusion: Prolonged DML and reduced amplitudes were observed in the motor nerve conduction of ALS patients in the early period. The results of the present study also support the presence of split-hand phenomenon even in early period of limb-onset ALS (both upper and lower). These findings suggest that nerve conduction studies and electrophysiologically detected split-hand sign are important clues for the early diagnosis of ALS in case of heterogeneous clinical phenotype.
- Open Access
- 30 June 2021
- Published by AVES YAYINCILIK A.Ş. in Archives of Rheumatology
- Vol. 36 (2) , 219-226
Positive effects of ocrelizumab in patients with familial mediterranean fever and coexistent multiple sclerosis
Objectives: This study aims to evaluate the effects of ocrelizumab (OCZ) on familial Mediterranean fever (FMF) attacks in multiple sclerosis (MS) patients with FMF (MS+FMF patients). Patients and methods: This retrospective observational study included 11 patients (2 males, 9 females; mean age 46.6±9.2; range, 22 to 55 years) with MS+FMF hospitalized between January 2016 and July 2019. Demographic, clinical, and laboratory parameters and patient reported outcomes were analyzed in patients treated with OCZ for 18 months. Results: Combining OCZ with colchicine in MS+FMF patients significantly reduced the frequency of FMF attacks (p=0.003) and the frequency of joint attacks (p=0.002). Consistent with the clinical improvement, the maximum serum C-reactive protein levels were significantly decreased after combination therapy compared to before combination therapy (p=0.003). MS+FMF patients reported that FMF disease activity improved after OCZ therapy (Visual Analog Scale [VAS] 74±9.6 vs. VAS 46.5±8.1 mm, p=0.003). Conclusion: Ocrelizumab therapy led to a prominent decrease in the frequency of FMF attacks, alleviated functional impairment, and improved quality of life in MS+FMF patients.
- 30 June 2021
- Published by AVES YAYINCILIK A.Ş. in Archives of Rheumatology
- Vol. 36 (2) , 219-226
Open AccessPositive effects of ocrelizumab in patients with familial mediterranean fever and coexistent multiple sclerosis
Objectives: This study aims to evaluate the effects of ocrelizumab (OCZ) on familial Mediterranean fever (FMF) attacks in multiple sclerosis (MS) patients with FMF (MS+FMF patients). Patients and methods: This retrospective observational study included 11 patients (2 males, 9 females; mean age 46.6±9.2; range, 22 to 55 years) with MS+FMF hospitalized between January 2016 and July 2019. Demographic, clinical, and laboratory parameters and patient reported outcomes were analyzed in patients treated with OCZ for 18 months. Results: Combining OCZ with colchicine in MS+FMF patients significantly reduced the frequency of FMF attacks (p=0.003) and the frequency of joint attacks (p=0.002). Consistent with the clinical improvement, the maximum serum C-reactive protein levels were significantly decreased after combination therapy compared to before combination therapy (p=0.003). MS+FMF patients reported that FMF disease activity improved after OCZ therapy (Visual Analog Scale [VAS] 74±9.6 vs. VAS 46.5±8.1 mm, p=0.003). Conclusion: Ocrelizumab therapy led to a prominent decrease in the frequency of FMF attacks, alleviated functional impairment, and improved quality of life in MS+FMF patients.
- 19 May 2020
- Published by Springer Nature in Sleep and Breathing
- Vol. 25 (1) , 257-262
The prevalence of restless legs syndrome in patients undergoing coronary angiography and its relationship with the severity of coronary artery stenosis
Purpose Results from studies on the relationship between restless legs syndrome (RLS) and coronary artery disease (CAD) are conflicting. Some studies associate RLS with CAD by heart rate variability, blood pressure variability, and other autonomic, neuronal reasons, while other studies do not support these observations. The aim of this study was to investigate the prevalence of RLS in patients undergoing coronary angiography for CAD and to assess RLS prevalence with severity of CAD. Methods After inclusion and exclusion criteria were applied, enrolled patients with less than 50% coronary artery stenosis by angiography (0–49%) were assigned to group 1, and patients with 50% or more coronary artery stenosis were assigned to group 2. Patients were diagnosed with RLS if they met all five essential criteria of the International RLS study group. RLS prevalence and other comorbidities were compared between the two groups. Results Of 126 patients, 74 men (59%), mean age 64.0 ± 8.7 years, mean BMI 29.6 kg/m2, 47 (37%) were assigned to group 1 (no or nonobstructive CAD) and 79 (63%) were assigned to group 2 (obstructive CAD). No significant differences were found between the groups in terms of mean age, BMI, gender, or prevalence of hypertension, hypercholesterolemia, and DM. The prevalence of RLS in group 2 (29%) was significantly higher than in group 1 (15%), p = 0.013. Conclusion These results suggest that prevalence of RLS is associated with CAD and with CAD severity. We conjecture that RLS may be related to vascular endothelial dysfunction in cardiovascular disease.
- 19 May 2020
- Published by Springer Nature in Sleep and Breathing
- Vol. 25 (1) , 257-262
The prevalence of restless legs syndrome in patients undergoing coronary angiography and its relationship with the severity of coronary artery stenosis
Purpose Results from studies on the relationship between restless legs syndrome (RLS) and coronary artery disease (CAD) are conflicting. Some studies associate RLS with CAD by heart rate variability, blood pressure variability, and other autonomic, neuronal reasons, while other studies do not support these observations. The aim of this study was to investigate the prevalence of RLS in patients undergoing coronary angiography for CAD and to assess RLS prevalence with severity of CAD. Methods After inclusion and exclusion criteria were applied, enrolled patients with less than 50% coronary artery stenosis by angiography (0–49%) were assigned to group 1, and patients with 50% or more coronary artery stenosis were assigned to group 2. Patients were diagnosed with RLS if they met all five essential criteria of the International RLS study group. RLS prevalence and other comorbidities were compared between the two groups. Results Of 126 patients, 74 men (59%), mean age 64.0 ± 8.7 years, mean BMI 29.6 kg/m2, 47 (37%) were assigned to group 1 (no or nonobstructive CAD) and 79 (63%) were assigned to group 2 (obstructive CAD). No significant differences were found between the groups in terms of mean age, BMI, gender, or prevalence of hypertension, hypercholesterolemia, and DM. The prevalence of RLS in group 2 (29%) was significantly higher than in group 1 (15%), p = 0.013. Conclusion These results suggest that prevalence of RLS is associated with CAD and with CAD severity. We conjecture that RLS may be related to vascular endothelial dysfunction in cardiovascular disease.
- 1 September 2017
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 354 (3) , 319-324
Neuroprotective Effects of Eexenatide in a Rotenone-Induced Rat Model of Parkinson’s Disease
- 1 September 2017
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 354 (3) , 319-324
Neuroprotective Effects of Eexenatide in a Rotenone-Induced Rat Model of Parkinson’s Disease
- 1 January 2017
- Published by Baycinar Tibbi Yayincilik in Ağrı - The Journal of The Turkish Society of Algology
- Vol. 30 (1) , 12-17
Characteristics of headache and its relationship to disease severity in patients with Crimean-Congo hemorrhagic fever
Crimean-Congo Hemorrhagic Fever (CCHF) is a fatal, tick-borne disease. The classic clinical presentation of CCHF is characterized by sudden onset of high fever, chills, and severe headache. There are no previous reports on the characteristics of headaches caused by CCHF. Therefore, we investigated the relationship between CCHF-induced headache and the clinical course of the disease. We included 60 patients with headache diagnosed with CCHF; they were divided into two groups: group 1 included patients with hospital stay 7 days. The control group included 43 viral pneumonia patients with headache. Patients described the characteristics of headaches and also self-rated the severity with a numeric pain scale that classified headache as either mild or severe. In the group with CCHF, 66.7% of the reported headaches met criteria for diagnosis of migraine. This ratio was significantly higher than that in the control group (37.5%). The headache severity scores in group 1 were lower than those in group 2. The hospitalization length was shorter (p=0.004) and the platelet levels were higher in CCHF patients with mild headache compared with CCHF patients with severe headache (p=0.005). CCHF patients had more often and severe headaches than the controls. The severity of headache may be associated with the severity of vascular endothelial damage, vasodilatation, and abnormal release of inflammatory cytokines in CCHF similar in migraine. Most CCHF patients experienced migraine-like headaches, suggesting that cerebral vessel involvement might be important in both CCHF and migraine.
- 1 January 2017
- Published by Baycinar Tibbi Yayincilik in Ağrı - The Journal of The Turkish Society of Algology
- Vol. 30 (1) , 12-17
Characteristics of headache and its relationship to disease severity in patients with Crimean-Congo hemorrhagic fever
Crimean-Congo Hemorrhagic Fever (CCHF) is a fatal, tick-borne disease. The classic clinical presentation of CCHF is characterized by sudden onset of high fever, chills, and severe headache. There are no previous reports on the characteristics of headaches caused by CCHF. Therefore, we investigated the relationship between CCHF-induced headache and the clinical course of the disease. We included 60 patients with headache diagnosed with CCHF; they were divided into two groups: group 1 included patients with hospital stay 7 days. The control group included 43 viral pneumonia patients with headache. Patients described the characteristics of headaches and also self-rated the severity with a numeric pain scale that classified headache as either mild or severe. In the group with CCHF, 66.7% of the reported headaches met criteria for diagnosis of migraine. This ratio was significantly higher than that in the control group (37.5%). The headache severity scores in group 1 were lower than those in group 2. The hospitalization length was shorter (p=0.004) and the platelet levels were higher in CCHF patients with mild headache compared with CCHF patients with severe headache (p=0.005). CCHF patients had more often and severe headaches than the controls. The severity of headache may be associated with the severity of vascular endothelial damage, vasodilatation, and abnormal release of inflammatory cytokines in CCHF similar in migraine. Most CCHF patients experienced migraine-like headaches, suggesting that cerebral vessel involvement might be important in both CCHF and migraine.